SCANGOS GEORGE A 4
4 · Vir Biotechnology, Inc. · Filed Oct 24, 2024
Insider Transaction Report
Form 4
SCANGOS GEORGE A
Director
Transactions
- Other
Common Stock
2024-10-23−598,270→ 1,151,730 total(indirect: See footnote) - Other
Common Stock
2024-10-23−598,270→ 1,151,730 total(indirect: See footnote) - Other
Common Stock
2024-10-23+598,270→ 719,259 total - Other
Common Stock
2024-10-23+598,270→ 598,270 total(indirect: See footnote)
Holdings
- 33,629(indirect: See footnote)
Common Stock
- 179,930(indirect: See footnote)
Common Stock
Footnotes (6)
- [F1]Transfer without consideration for tax planning purposes.
- [F2]The shares are held in the name of the George A Scangos 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
- [F3]The shares are held by the spouse of the reporting person.
- [F4]The shares are held in the name of Leslie Wilson 2023 Annuity Trust, of which the reporting person and his spouse are Trustees.
- [F5]The shares are held in the name of George A. Scangos, as Trustee of the Scangos-Wilson Family Trust dated May 12, 2011.
- [F6]The shares are held in the name of the Scangos 2018 Grandchildren's Trust, of which the reporting person and his spouse are Trustees.